Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes

Trial Profile

Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes

Recruiting
Phase of Trial: Phase III

Latest Information Update: 17 Jul 2018

At a glance

  • Drugs Fluoxetine (Primary)
  • Indications Anxiety disorders; Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Aug 2016 Planned number of patients changed from 2330 to 2530.
    • 08 Jul 2014 Planned number of patients changed from 1890 to 2330 as reported by ClinicalTrials.gov.
    • 17 Feb 2012 Planned number of patients changed from 1750 to 1890 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top